Search Results - "Freyschlag, C F"

Refine Results
  1. 1

    Preoperative prediction of language function by diffusion tensor imaging by Freyschlag, C. F., Kerschbaumer, J., Pinggera, D., Bodner, T., Grams, A. E., Thomé, C.

    Published in Brain informatics (01-09-2017)
    “…For surgery of eloquent tumors in language areas, the accepted gold standard is functional mapping through direct cortical stimulation (DCS) in awake patients…”
    Get full text
    Journal Article
  2. 2

    Prolonged Administration of Temozolomide in Adult Patients with Anaplastic Glioma by FREYSCHLAG, C. F, SMOLCZYK, D. R, JANZEN, E, SCHMIEDER, K, THOME, C, LOHR, F, WENZ, F, WEISS, C, TUETTENBERG, J, SEIZ, M

    Published in Anticancer research (01-11-2011)
    “…Prolonged administration of temozolomide is widely used in patients with glioblastoma; whereas the treatment of anaplastic glioma differs between…”
    Get full text
    Journal Article
  3. 3

    Awake brain mapping of cortex and subcortical pathways in brain tumor surgery by Freyschlag, C F, Duffau, H

    Published in Journal of neurosurgical sciences (01-12-2014)
    “…Awake surgery is not a new technique: this is a new philosophy. Indeed, in surgery for diffuse gliomas performed in awake patients, the goal is not anymore to…”
    Get more information
    Journal Article
  4. 4

    Effect of mouth opening on bypass function after combined revascularization for Moyamoya disease by Freyschlag, C F, Seiz, M, Brockmann, M A, Scharf, J, Stier, R W, Schubert, G A, Thomé, C, Schmiedek, P

    Published in Acta neurochirurgica. Supplement (2011)
    “…Moyamoya disease represents a rare steno-occlusive disease of the internal carotid artery (ICA) with a reactive and pathological basal network of collateral…”
    Get more information
    Journal Article
  5. 5

    How I do it—optimizing radiofrequency ablation in spinal metastases using iCT and navigation by Kavakebi, Pujan, Freyschlag, C. F., Thomé, C.

    Published in Acta neurochirurgica (01-10-2017)
    “…Background Exact positioning of the radiofrequency ablation (RFA) probe for tumor treatment under fluoroscopic guidance can be difficult because of potentially…”
    Get full text
    Journal Article
  6. 6

    Serious tumor seeding after brainstem biopsy and its treatment—a case report and review of the literature by Pinggera, D., Kvitsaridtze, I., Stockhammer, G., Eisner, W., Thomé, C., Freyschlag, C. F., Moser, P., Kerschbaumer, J.

    Published in Acta neurochirurgica (01-04-2017)
    “…Stereotactic brain biopsies for histopathological diagnosis are a common technique in case of intracranial lesions, particularly in those not amenable for…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Response to temozolomide in supratentorial multifocal recurrence of malignant ependymoma by Freyschlag, C F, Tuettenberg, J, Lohr, F, Thomé, C, Schmieder, K, Seiz, M

    Published in Anticancer research (01-03-2011)
    “…Intracranial anaplastic ependymomas are a very rare entity within the group of adult CNS neoplasms. Thus, no standard adjuvant therapy after surgical resection…”
    Get full text
    Journal Article
  9. 9

    P08.02.B The Clinical Frailty Scale as predictor of overall survival after resection of high-grade glioma by Klingenschmid, J, Krigers, A, Pinggera, D, Kerschbaumer, J, Thomé, C, Freyschlag, C F

    Published in Neuro-oncology (Charlottesville, Va.) (05-09-2022)
    “…Abstract Background The Clinical Frailty Scale (CFS) describes the general level of fitness or frailty and is widely used in geriatric medicine, intensive care…”
    Get full text
    Journal Article
  10. 10

    P11.10.A An assessment of predictive factors for overall survival in glioblastoma - MGMT methylation is solely important for younger patients by Krigers, A, Cosar, T, Kerschbaumer, J, Demetz, M, Pinggera, D, Thomé, C, Freyschlag, C F

    Published in Neuro-oncology (Charlottesville, Va.) (05-09-2022)
    “…Abstract Background Diverse groups of factors - neuropathological characters, tumor position and epidemiological data - have been proposed for outcome…”
    Get full text
    Journal Article
  11. 11

    P08.04.B The Clinical Frailty Scale is superior to the Karnofsky Performance Status as predictor of overall survival in patients with surgical treatment of brain metastases by Krigers, A, Pichler, N, Kerschbaumer, J, Demetz, M, Klingenschmid, J, Thomé, C, Freyschlag, C F

    Published in Neuro-oncology (Charlottesville, Va.) (05-09-2022)
    “…Abstract Background The Clinical Frailty Scale (CFS) evaluates patients’ level of frailty on a scale from 1 (very fit) to 9 (terminally ill) and is commonly…”
    Get full text
    Journal Article
  12. 12

    P12.05.B Impact of GAP-43 and actin expression on the outcome and overall survival in diffuse and anaplastic gliomas by Krigers, A, Demetz, M, Moser, P, Kerschbaumer, J, Brawanski, K R, Thomé, C, Freyschlag, C F

    Published in Neuro-oncology (Charlottesville, Va.) (05-09-2022)
    “…Abstract Background Distant intercellular communication in gliomas is based on the expansion of tumor microtubuli (TMs), where actin forms cytoskeleton and…”
    Get full text
    Journal Article
  13. 13

    P01.154 Volumetric response to TTFields in newly diagnosed GBM by Kerschbaumer, J, Freyschlag, C F, Pinggera, D, Thomé, C

    Published in Neuro-oncology (Charlottesville, Va.) (19-09-2018)
    “…Abstract Background Optune TTField treatment is an established, non-invasive therapy for patients with newly diagnosed or recurrent glioblastoma (GBM)…”
    Get full text
    Journal Article
  14. 14

    OS02.7.A The role of epilepsy in elderly patients with Glioblastoma: An Austrian multicenter analysis by Demetz, M, Hecker, C, Krigers, A, Kerschbaumer, J, Pöppe, J, Geiger, P, Spinello, A, Griessenauer, C J, Thomé, C, Schwartz, C, Freyschlag, C F

    Published in Neuro-oncology (Charlottesville, Va.) (05-09-2022)
    “…Abstract Background Higher age is a significant predictor of poor outcome in glioblastoma multiforme (GBM) patients. Thus, acquisition of a better…”
    Get full text
    Journal Article
  15. 15

    P01.002 Evaluation of 31-P-MR-Spectroscopy in malignant glioma correlated with histopathological results and intraoperative fluorescence by Freyschlag, C F, Kerschbaumer, J, Steiger, R, Pinggera, D, Gizewski, E R, Thomé, C

    Published in Neuro-oncology (Charlottesville, Va.) (19-09-2018)
    “…Abstract Background The diffuse infiltration of malignant gliomas underlines the necessity for utmost radicality in surgical treatment with respect to…”
    Get full text
    Journal Article
  16. 16
  17. 17

    P09.07 The use of programmable shunts in patients treated with Tumor Treating Fields: Multicentric Case Series by Schreiber, L., Rapp, M., Sabel, M., Onken, J., Misch, M., Kinzel, A., Thomé, C., Scholz, M., Vajkoczy, P., Freyschlag, C. F.

    Published in Neuro-oncology (Charlottesville, Va.) (01-05-2017)
    “…OBJECTIVE: Tumor Treating Fields (TTFields) are a non-invasive, low intensity, intermediate frequency, alternating electric fields serving as anti-mitotic…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Management of patients with low-grade gliomas - a survey among German neurosurgical departments by Seiz, M, Freyschlag, C F, Schenkel, S, Weiss, C, Thomé, C, Schmieder, K, Stummer, W, Tuettenberg, J

    Published in Central European neurosurgery (01-11-2011)
    “…The diagnosis and treatment of low-grade gliomas (LGG) are multimodal. Today, there is no defined standard in diagnosis and treatment. Controversies are, in…”
    Get more information
    Journal Article
  20. 20